NCT06608472 - Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension | Biotech Hunter

Enrollment

292

Participants

Timeline

Start Date

November 30, 2026

Primary Completion Date

April 30, 2028

Study Completion Date

October 30, 2029

Conditions

Essential Arterial Hypertension

Interventions

DRUG

N0877

1 tablet of N0877 and 1 tablet of Placebo of Benicar HCT®

DRUG

Benicar HCT ® Tablets 40 mg/25 mg

1 tablet of Benicar HCT® and 1 tablet of Placebo of N0877

Trial Locations (1)

Eurofarma Laboratórios S.A, Itapevi